ISSN: 0889-8588

Journal Home

Journal Guideline

Hematology/Oncology Clinics of North America Q1 Unclaimed

W.B. Saunders United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Hematology/Oncology Clinics of North America is a journal indexed in SJR in Hematology and Oncology with an H index of 98. It has an SJR impact factor of 1,255 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,255.

Hematology/Oncology Clinics of North America focuses its scope in these topics and keywords: approaches, assessmentneurologic, blood, bloodless, cytometry, dyscrasiasthe, emission, erythropoietinflow, ffluorodeoxyglucose, human, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Hematology (Q1) Oncology (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Hematology/Oncology Clinics of North America

1,255

SJR Impact factor

98

H Index

95

Total Docs (Last Year)

270

Total Docs (3 years)

6056

Total Refs

802

Total Cites (3 years)

233

Citable Docs (3 years)

2.59

Cites/Doc (2 years)

63.75

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Blood Q1
Blood Cancer Journal Q1
The Lancet Haematology Q1
Leukemia Q1
Experimental Hematology and Oncology Q1

Compare this journals

Aims and Scope

Best articles by citations

IMMUNOREGULATORY MECHANISMS IN MULTIPLE MYELOMA

HIV-ASSOCIATED HODGKIN'S DISEASE

CLINICAL ASPECTS OF APLASTIC ANEMIA

ENDOCRINOPATHY AND ECTOPIC HORMONES IN MALIGNANCY

PALLIATIVE MEDICINE AND THE MEDICAL ONCOLOGIST

THERAPY-RELATED MYELOID LEUKEMIA

HEMOLYTIC DISORDERS ASSOCIATED WITH CANCER

CLINICAL COURSE AND THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALPHA AND CHEMOTHERAPY

Treatment of Therapy-Related Acute Myelogenous Leukemia and Myelodysplastic Syndromes

Pathology of Epithelial Tumors

AUTOLOGOUS TRANSPLANTATION FOR THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA

MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE AND SOLITARY PLASMACYTOMA

SHOW MORE ARTICLES

INNOVATIVE THERAPY FOR CHRONIC MYELOGENOUS LEUKEMIA

Early Diagnosis and Screening

ETIOLOGY AND PATHOGENESIS OF AIDS-RELATED NON-HODGKIN'S LYMPHOMA

CAN SCREENING FOR EARLY-STAGE PROSTATE CANCER BE RATIONALIZED?

PULMONARY COMPLICATIONS

INTRAEMBRYONIC HEMATOPOIETIC STEM CELLS

BIOLOGY AND MANAGEMENT OF AIDS-ASSOCIATED PRIMARY CNS LYMPHOMAS

BIOLOGY AND THERAPY OF IMMUNOGLOBULIN DEPOSITION DISEASES

TARGETED THERAPY FOR LYMPHOMA WITH PEPTIDES

MALIGNANT HISTIOCYTIC DISORDERS IN CHILDREN

MALIGNANT HISTIOCYTOSIS

PROGNOSTIC MARKERS IN RESECTABLE NON-SMALL CELL LUNG CANCER